Enliven Therapeutics Inc (ELVN)

Oct 14, 2025

Tools to monitor Enliven Therapeutics Inc. recovery probabilityMarket Risk Report & Real-Time Market Trend Scan - newser.com

Oct 14, 2025

Oct 14, 2025

Enliven Therapeutics Inc. recovery potential after sell off2025 Retail Activity & Real-Time Stock Entry Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

Real time breakdown of Enliven Therapeutics Inc. stock performanceEntry Point & Free Technical Confirmation Trade Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

What the charts say about Enliven Therapeutics Inc. todayShort Setup & Daily Volume Surge Trade Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

How to read the order book for Enliven Therapeutics Inc.July 2025 Setups & AI Forecast Swing Trade Picks - newser.com

Oct 14, 2025

Oct 14, 2025

Strategies to average down on Enliven Therapeutics Inc.July 2025 Patterns & Expert Curated Trade Setups - newser.com

Oct 14, 2025

Oct 13, 2025

Heatmap analysis for Enliven Therapeutics Inc. and competitorsJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Automated trading signals detected on Enliven Therapeutics Inc.Trade Exit Summary & Consistent Return Investment Signals - newser.com

Oct 13, 2025

Oct 12, 2025

Chart based exit strategy for Enliven Therapeutics Inc.July 2025 Fed Impact & Daily Stock Trend Reports - newser.com

Oct 12, 2025

Oct 10, 2025

Enliven Therapeutics (NASDAQ:ELVN) Trading 6.1% HigherHere's Why - MarketBeat

Oct 10, 2025

Oct 10, 2025

Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) COO Sells 6,667 Shares of Stock - MarketBeat

Oct 10, 2025

Oct 10, 2025

Volatility clustering patterns for Enliven Therapeutics Inc.Rate Cut & Free Weekly Watchlist of Top Performers - newser.com

Oct 10, 2025

Oct 10, 2025

Is a relief rally coming for Enliven Therapeutics Inc. holdersWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com

Oct 10, 2025

Oct 10, 2025

Long term hold vs stop loss in Enliven Therapeutics Inc.2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com

Oct 10, 2025

Oct 10, 2025

Enliven Therapeutics (NASDAQ:ELVN) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

Using Ichimoku Cloud for Enliven Therapeutics Inc. technicals2025 Analyst Calls & Consistent Growth Equity Picks - newser.com

Oct 10, 2025

Oct 09, 2025

Enliven Therapeutics COO Patel sells $133,992 in stock By Investing.com - Investing.com South Africa

Oct 09, 2025

Oct 09, 2025

Enliven Therapeutics COO Patel sells $133,992 in stock - Investing.com

Oct 09, 2025

Oct 09, 2025

Short interest data insights for Enliven Therapeutics Inc.Market Activity Report & Real-Time Volume Spike Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

What moving averages say about Enliven Therapeutics Inc.Market Activity Report & Low Risk Growth Stock Ideas - newser.com

Oct 09, 2025

Oct 09, 2025

Why retail investors favor Enliven Therapeutics Inc. stockQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com

Oct 09, 2025

Oct 09, 2025

Is now a turning point for Enliven Therapeutics Inc.2025 Volatility Report & Smart Money Movement Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

Enliven Therapeutics stock falls after pricing capital raise of $200M via securities offering - MSN

Oct 08, 2025

Oct 06, 2025

Developing predictive dashboards with Enliven Therapeutics Inc. dataStop Loss & Weekly Sector Rotation Insights - newser.com

Oct 06, 2025

Oct 05, 2025

Will Enliven Therapeutics Inc. rebound enough to break evenJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Top chart patterns to watch in Enliven Therapeutics Inc.July 2025 Retail & Risk Managed Investment Signals - newser.com

Oct 05, 2025

Oct 05, 2025

Will Enliven Therapeutics Inc. stock recover after recent drop2025 Earnings Impact & Precise Swing Trade Alerts - newser.com

Oct 05, 2025

Oct 01, 2025

Benjamin Hohl Sells 3,250 Shares of Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat

Oct 01, 2025

Sep 30, 2025

Enliven Therapeutics (NASDAQ:ELVN) Insider Sells $81,000.00 in Stock - MarketBeat

Sep 30, 2025

Sep 30, 2025

Enliven Therapeutics CFO sells $22,524 in stock - MSN

Sep 30, 2025

Sep 30, 2025

Enliven Therapeutics (NASDAQ:ELVN) CEO Samuel Kintz Sells 3,700 Shares - MarketBeat

Sep 30, 2025